Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)

NCT01371201 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT01371201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01371201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Phase 2
Overall status
Completed
Start date
December 22, 2011
Completion date
April 20, 2021
Enrollment
78 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

malignant progressive pheochromocytoma and paraganglioma (ppgl)